Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yeah, when the buying stops at the retail level, MMs turn to Shorts to supplement their income. Replacement of 'borrowed' shares by Shorts become easily replaced by even cheaper shares. On and on until retail buying starts up again.
Z-t, appears they have something up their sleeve ... got my interest again since pps has dropped with little reason why other than MM games.
It’s the OTC…. Whatever the current Authorized shares are with OTC companies, dilution always seems likely. AS change is simple either way, to reduce or to add. They aren’t currently nor have they in the last 1 1/2 years, diluted, they also had $2million+ cash on hand for operations after Q1, we’ll see in a week or two, how much they spent in Q2
What about those authorized shares? Can't we assume that they will start tapping those for operational needs? Dilution seems to be likely.
Lol, perfect catch 22! They had plenty of opportunity to add shares this spring with the buy back, but they did not.
Put out PRs - they’re pumping to dilute!!
There has been No dilution for 2 years - they can’t because nobody wants it!
Lol
Only added a handful because nobody wants to buy this garbage.
Caveat Emptor
.
.
Idk, we’ll see in a a couple weeks if they actually spent the 2.5 million cash on hand that they’ve held onto for a year, you’d think they’d want to put it to work. They’ve only added a handful of shares to the OS in a couple years…. Like 12.1 million to 12.25 million.
I'm not optimistic based on the fact the stock is below .03, but the market cap is ridiculous. Hopefully one day it'll make a run and stay around a more reasonable market cap (.20-.30 in my opinion).
For sure! It just fell flat compared to every expectation, even dampened expectations. The small revenue vs expectations should have been explained to shareholders in April, maybe the QnA interview will answer a couple of those question. I wouldn’t count on that, I think they’ll keep letting their quarterly’s do the talking, and hopefully the revenue grows a lot, and they keep dilution away, because the Qs so far have said stay away!
If all the warrants converted right now at current PPS would give a $3 mil market cap on $1+ mil revenue
Lol, what money was the company afraid to lose? Lmao
People only got paid so they wouldn’t get sued. They paid Paul and borrowed from Mary.
Leaves ticker as garbage
At least the company HAS revenue and potential unlike many OTC basement-dwelling run stocks
Not really, not quite what it was billed on either side…. Just a low revenue company, expanding to what ends? Who knows, the company doesn’t say anything.
I do know some people thought they wouldn’t pay back LAHO shareholders or file an 8k/a, those people were dead wrong, some were even successful in convincing people to dump their LAHO shares for tax write-offs, lmao
Hell, even I was wrong predicting somewhere between 5-10 mil in revs, an awful lot of hubbub here for a fledgling company
Train wreck scams are entertaining.
News*
https://www.globenewswire.com/news-release/2022/08/01/2489271/0/en/Global-Stem-Cells-Group-Expands-Its-Stem-Cell-Therapy-and-Regenerative-Medicine-Centers-to-Indonesia.html
QnA Video supposedly gets released today
You warned about them not pumping? I agree, their filings don’t look good due to making LAHO shareholders whole, but they are in a wide open field, and could theoretically grow revenue like crazy at some point…. Could you post your warning posts please, FYI, calling an otc company pps going down does not make you a prognosticator, it would be like saying your gonna get wet if you go golfing when there is a 90% chance of rain
Someone got tired of waiting. Pathetic that they’ve let it drop this far.
I warned about this. Bagholders once again are stuck. SEC filings are awful too.
The devil whispering in one ear wants me to just dump MSSV into sub-penny land, but the angel in the other ear is telling me to hold and not hurt other shareholders. I can afford to take a total loss so I'll listen to the angel for now and hope the company comes through in the near future.
What are you talking about? They put 25 posts a week on Facebook. They just don’t talk about the stock, if they did, they would get called pumpers.
I'm thinking the SEC has a been poking around and thats why theses lying scammers have been laying low.
Caveat Emptor
.
.
I expect volume when they are ready for volume. Until then, wear the holders out and take their shares for as cheap as possible. They may be ready in a month, 6 months, a year, who knows. Still on watch for a good time to buy. I’m looking for buy signals, awareness and significant volume increase. I’d rather buy above .10 on the move than sit and watch paint dry.
Waypoint Refinery
What is the name of the Discord channel ?
Mines still good, looking at the feed, someone’s got ya taken care of
Some volume... have not seen that for a while !
What happened to the Discord forum for MSSV? I was on it this morning and then it was gone (or I was booted out which makes no sense). Now I can't even find it.
Still here but getting ready to bail out if we don't hear anything in the next few weeks.
ZZZZZZZZZZZZZZZZZZZZZZZZZZ is anyone there ?
Call your broker and they can help you get started.
Mine is still the number I got when it was suspended. How'd you get it
Thanks Chat! I need to do better with my DD.
Still waiting for share money! Applied about 4 months ago. Broker messed up for a month by trying to deposit shares into my account instead of withdrawing them. Shares were finally withdrawn 8 weeks ago.
When the money hopefully shows up someday, I still plan to buy MSSV shares. The company has to be suffering bad economic times like everyone else, but when that passes, maybe I'll get lucky and get dirt cheap shares!
Why a Q? They are up to date on filings and the latest quarterly is a disaster
https://www.otcmarkets.com/filing/html?id=15832819&guid=JbnwkWQN2-Y4B3h
I got my money about 3 months ago, 4 times what I had in it. All we need is a Q and we are taking off again.
I haven't checked in months, laho shareholders every getting anything
Ya, the Pakistani government wants to put gobs of money into stem cell clinics…. They have many health problems that stem cells show promise in helping or curing. Same with Indonesia. Mexico seems to love the stem cells for aesthetic fixes, big market for that in South America
they put out the news on a national wire. It would have gotten plenty of eyes.
No one wants to invest in a company like this. The history, their filings and doing business in Pakistan?
Come on man… it’s another bagholders dream
It is legit news, but without any explanation of the impact to financials, it’s not exactly something that will attract new share buyers.
It would be great if/when they follow through with their promise to tell shareholders the outline on how they are gonna grow revenue, and explain why their revenue isn’t close to what the market thought it would be, it even fell short of modest revenue predictions.
There’s probably less than 100 people that even know MSSV is a stem cell company, lol. Which is why I’d like the company to engage shareholders more, like I said, catch 22, put out news items, get called pumpy, don’t put our news items, no trader/investor even knows about you.
Well, the market doesn’t seem to believe it…
I don’t think it’s fluffy at all. It’s a partnership in a country that’s growing very fast in the stem cell field.
I don’t care if some people perceive it as pumpy, it’s legit news so they need to promote themselves anyway possible.
LAS VEGAS, NV, Feb. 05, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Meso Numismatics, Inc. (“Meso Numismatics” or the “Company”) (MSSV), a regenerative medicine company is pleased to announce that it will be undergoing a name change from Meso Numismatics Inc. to Regenerative Medical Technology Group Inc. to better reflect the company’s business. The Company will also change its authorized shares outstanding from the current 6.5 billion to 100 million shares. Please see the Information Statement on Schedule 14C filed by the Company on February 2, 2024, and other Company filings at www.sec.gov.
About Meso Numismatics: Meso Numismatics Corp is a regenerative medicine company offering diverse products and services through its wholly owned subsidiary Global Stem Cells Group. The Company currently has a network of 26 clinics in 21 countries that carry its banner and has its own clinic in Cancun and is currently building another one in Dubai. The Company distributes stem cells and other regenerative based cell lines, and equipment internationally and also specializes in education and training physicians in the area of regenerative medicine.
For more information on Global Stem Cells Group please visit: www.stemcellsgroup.com
Forward-Looking Statements
Some information in this document constitutes forward-looking statements or statements which may be deemed or construed to be forward-looking statements, such as the closing of the share exchange agreement. The words “plan”, "forecast", "anticipates", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in the Company's filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Lans Holdings Inc., herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Lans Holdings Inc. disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.
For further information, please contact:
Investor.relations@mssvinc.com
Telephone: (800) 956-3935
The Cancun clinic is currently active and is finalizing its full build out, which will double its footprint by the end of February. The clinic is also comprised of a lab where stem cell cultures can be produced. The Cancun clinic currently offers numerous procedures for multiple indications including: hormone replacement, autoimmune, neurodegenerative, osteoarthritis, cardiovascular, aesthetic/anti-aging, hair transplant, sports medicine, spinal cord injury, MS, and autism. The Company is in the process of building out a clinic in Dubai that will offer similar procedures to those in the Cancun location. The Dubai clinic is expected to be fully operational by the end of the second quarter of this year.
The Company plans to close on two additional locations for new clinics, one by the end of the third quarter and one by the end of the fourth quarter of this year. Both of these clinics are expected to be operational by the end of the second quarter of 2025.
The Company also has a collaboration with an Istanbul based clinic where the Company refers patients and receives patient referrals on various patient procedures.
The Company operates in the stem cell therapy market, which is expected to grow from $11.2 billion in 2022 to $31.4 billion by 2030 according to Precedence Research. The Company has also entered the exosome market, which is expected to grow from $250 million in 2022 to $3.2 billion by 2032 according to Global Market Insights.
The Company is actively collaborating with leading research institutions, universities, and industry experts to accelerate the development and commercialization of regenerative medical solutions. These partnerships create a collaborative ecosystem that fosters scientific excellence and ensures that the Company remains at the forefront of innovation, contributing to medical advancements and expanding its range of products. With a global vision, the Company is dedicated to making a positive impact on healthcare worldwide. The company is exploring opportunities to expand its reach and make its cutting-edge medical procedures accessible to patients across borders.
"We are thrilled to be at the forefront of regenerative medicine, bringing hope to patients and pushing the boundaries of what is possible in biotechnology. Our commitment to innovation and collaboration underscores our mission to make a lasting impact on the lives of individuals facing challenging medical conditions," said David Christensen, CEO and President of the Company.
The driving forces behind Global Stem Cells Group's strategy to increase revenue in 2024 involve a multifaceted approach within the rapidly expanding stem cell therapy market. As the wholly-owned subsidiary of the Company, Global Stem Cells Group specializes in cutting-edge stem cell research collaborations and physician training. The key components contributing to revenue growth include:
Certified Training Courses for Physicians - Offering specialized and certified training courses to physicians, ensuring they are equipped with the latest knowledge and skills in stem cell therapies. The Company is internationally recognized as an expert in the field of stem cells and regenerative medicine.
Manufacturing and Sales of the Latest Technology, Supplies, and Equipment - Engaging in the production and sale of state-of-the-art technology, supplies, and equipment related to stem cell applications, catering to the needs of medical professionals in the field.
Research and Development of Clinical Protocols - Investing in research and development collaborations to create advanced clinical protocols for stem cell applications, enhancing the efficacy and safety of treatments.
Regenerative Medical Clinics - Cancun, Dubai, and Istanbul, Provide standardized regenerative medical treatments. These treatments cover a spectrum of health issues, including musculoskeletal disorders, autoimmune diseases, aesthetics, and anti-aging.
Franchising Network of Regenerative Medical Practitioners - Establishing a network of franchised regenerative medical practitioners, potentially increasing the geographical reach and accessibility of stem cell treatments. Currently 26 clinics in 21 countries carry the Company's banner. This allows the Company to raise its global profile and branding and assist the company in bringing patients to its own clinics.
Turnkey Solutions for Stem Cell Processing Center Installation & Management - Offering comprehensive complete solutions for the installation and management of stem cell processing centers, providing a one-stop solution for practitioners entering the field.
By diversifying into these key areas Global Stem Cells Group aims to tap into various aspects of regenerative medicine, creating revenue streams through education, product sales, research, patient services, and strategic partnerships within the stem cell therapy market.
"We are excited to announce our significant growth across multiple channels, showcasing the strength and diversity of our business. The success in training, product sales, equipment sales, and patient procedures reflects our commitment to excellence in every facet of regenerative medicine," said Benito Novas, CEO and Founder of Global Stem Cells Group.
This press release should be read in conjunction with all of the Company's filings on www.sec.gov
About Meso Numismatics: Meso Numismatics, Inc. is a regenerative medicine company offering diverse products and services through its wholly owned subsidiary Global Stem Cells Group. The Company currently has a network of 26 clinics in 21 countries that carry its banner and has its own clinic in Cancun and is currently building another one in Dubai. The Company distributes stem cells and other regenerative based cell lines and equipment internationally and also specializes in educating and training physicians in the area of regenerative medicine.
For more information on Global Stem Cells Group please visit: www.stemcellsgroup.com
Forward Looking Statements
Some information in this document constitutes forward-looking statements or statements which may be deemed or construed to be forward-looking statements, such as the closing of the share exchange agreement. The words "plan", "forecast", "anticipates", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in the Company's filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Lans Holdings Inc., herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Lans Holdings Inc. disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.
For further information, please contact:
Investor.relations@mssvinc.com
Telephone: (800) 956-3935
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |